These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
435 related items for PubMed ID: 16756595
1. Hepatitis B virus blood screening: unfinished agendas. Comanor L, Holland P. Vox Sang; 2006 Jul; 91(1):1-12. PubMed ID: 16756595 [Abstract] [Full Text] [Related]
2. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP. Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546 [Abstract] [Full Text] [Related]
3. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA. Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909 [Abstract] [Full Text] [Related]
4. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group. Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857 [Abstract] [Full Text] [Related]
5. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101 [Abstract] [Full Text] [Related]
7. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China. Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR. Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161 [Abstract] [Full Text] [Related]
9. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233 [Abstract] [Full Text] [Related]
10. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K. Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154 [Abstract] [Full Text] [Related]
11. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R. Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [Abstract] [Full Text] [Related]
12. Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M, Polish Blood Transfusion Service Viral Study Group. Hepatology; 2006 Dec; 44(6):1666-74. PubMed ID: 17133474 [Abstract] [Full Text] [Related]
13. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ. Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905 [Abstract] [Full Text] [Related]
14. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC. Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605 [Abstract] [Full Text] [Related]
15. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M. Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990 [Abstract] [Full Text] [Related]
16. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Dreier J, Kröger M, Diekmann J, Götting C, Kleesiek K. Transfus Med; 2004 Apr; 14(2):97-103. PubMed ID: 15113374 [Abstract] [Full Text] [Related]
17. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE. Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604 [Abstract] [Full Text] [Related]
18. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ. Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856 [Abstract] [Full Text] [Related]
19. Nucleic acid testing to detect HBV infection in blood donors. Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W. N Engl J Med; 2011 Jan 20; 364(3):236-47. PubMed ID: 21247314 [Abstract] [Full Text] [Related]
20. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Katz L, Strong DM, Tegtmeier G, Stramer S. Transfusion; 2008 Nov 20; 48(11):2315-22. PubMed ID: 18647367 [Abstract] [Full Text] [Related] Page: [Next] [New Search]